ENDRA Life Sciences (NDRA) Trading Up 7.9% on Insider Buying Activity

ENDRA Life Sciences Inc (NASDAQ:NDRA) shares were up 7.9% on Monday after an insider bought additional shares in the company. The stock traded as high as $1.41 and last traded at $1.23. Approximately 517,248 shares changed hands during trading, an increase of 93% from the average daily volume of 268,613 shares. The stock had previously closed at $1.14.

Specifically, insider Michael Milos Thornton purchased 30,000 shares of the firm’s stock in a transaction that occurred on Thursday, May 16th. The shares were bought at an average price of $1.13 per share, for a total transaction of $33,900.00. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 11.40% of the company’s stock.

Separately, Lake Street Capital initiated coverage on ENDRA Life Sciences in a research note on Monday. They issued a “buy” rating on the stock.

ENDRA Life Sciences (NASDAQ:NDRA) last released its earnings results on Monday, March 11th. The company reported ($0.28) earnings per share for the quarter.

Hedge funds have recently added to or reduced their stakes in the business. National Asset Management Inc. purchased a new stake in ENDRA Life Sciences in the fourth quarter worth $35,000. Virtu Financial LLC boosted its position in ENDRA Life Sciences by 109.2% during the first quarter. Virtu Financial LLC now owns 28,602 shares of the company’s stock valued at $47,000 after purchasing an additional 14,930 shares in the last quarter. Creative Planning bought a new stake in ENDRA Life Sciences during the fourth quarter valued at about $53,000. Geode Capital Management LLC bought a new stake in ENDRA Life Sciences during the fourth quarter valued at about $71,000. Finally, ICM Asset Management Inc. WA boosted its position in ENDRA Life Sciences by 412.9% during the fourth quarter. ICM Asset Management Inc. WA now owns 671,226 shares of the company’s stock valued at $1,007,000 after purchasing an additional 540,356 shares in the last quarter. Institutional investors and hedge funds own 19.00% of the company’s stock.

TRADEMARK VIOLATION WARNING: This news story was first published by Community Financial News and is the sole property of of Community Financial News. If you are reading this news story on another site, it was copied illegally and reposted in violation of U.S. & international copyright and trademark laws. The correct version of this news story can be read at https://www.com-unik.info/2019/05/20/endra-life-sciences-ndra-trading-up-7-9-on-insider-buying-activity.html.

About ENDRA Life Sciences (NASDAQ:NDRA)

ENDRA Life Sciences Inc develops medical imaging technology based on the thermos-acoustic effect that improves the sensitivity and specificity of clinical ultrasound. It offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding.

Recommended Story: What is the formula for calculating total return?

Receive News & Ratings for ENDRA Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ENDRA Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit